Press "Enter" to skip to content

Clinical Implications of TITAN in mHSPC – Kim Chi and Michael Morris – UroToday

admin 0

Clinical Implications of TITAN in mHSPC – Kim Chi and Michael Morris  UroToday

Kim Chi, MD discusses the first results from TITAN: A phase 3 randomized, placebo-controlled, double-blind study of apalutamide (APA) vs. placebo (PBO) in …

“prostate cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *